Home / Market News / $PRGO

$PRGO news and market catalysts

The 7 most recent market catalysts affecting $PRGO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

7 catalysts 4 high impact 2 bullish 1 bearish Healthcare
Nov 4, 2026 Corporate Catalyst Neutral Impact 85
Perrigo Reports Third Quarter 2026 Financial Results
Perrigo Company plc announced its third-quarter 2026 financial results, revealing a decline in net sales to $989 million from $1,043 million year-over-year. This sales miss is attr…
Oct 29, 2026 Corporate Catalyst Neutral Impact 75
Jefferies LLC Acts as Financial Advisor to MeridianMade in Perrigo Divestiture
Perrigo Company plc is divesting its infant formula business to MeridianMade, a move that allows Perrigo to streamline its operations and focus on its core pharmaceutical and consu…
Oct 29, 2026 Corporate Catalyst Neutral Impact 65
Goldman Sachs Serves as Financial Advisor to Perrigo in Divestiture
Perrigo Company plc has announced that Goldman Sachs will serve as its financial advisor for a divestiture. This indicates Perrigo is actively pursuing a strategic transaction to s…
Oct 29, 2026 Corporate Catalyst Bullish Impact 80
Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade
Perrigo is selling its infant formula business to MeridianMade for an initial $40 million cash, with potential for an additional $135 million based on future performance. This move…
Oct 23, 2026 Corporate Catalyst Neutral Impact 55
Supreme Court of Ohio Rules in Favor of Perrigo Sales Corporation in Tax Dispute
The Supreme Court of Ohio's unanimous decision is a positive development for Perrigo Sales Corporation. The ruling clarifies that the company's Commercial Activity Tax (CAT) base s…
Aug 5, 2026 Corporate Catalyst Bullish Impact 85
Perrigo shares are trading higher after the company reported better-than-expected Q2 financial results and affirmed its FY26 adjusted EPS guidance above estimates.
This headline represents a significant corporate catalyst for Perrigo, as strong financial performance and optimistic future guidance directly impact investor confidence and stock …
Aug 5, 2026 Corporate Catalyst Bearish Impact 92
Perrigo Q2 Adj. EPS $0.50 Beats $0.34 Estimate, Sales $1.023B Beat $1.013B Estimate
Perrigo (PRGO) announced Q2 adjusted EPS of $0.50, significantly exceeding the consensus estimate of $0.34, indicating stronger-than-anticipated profitability. While EPS decreased …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.